Clinical Trial Update: The Role of Dexmedetomidine As Myocardial Protection In Pediatric Cyanotic Congenital Heart Disease Undergoing Open Cardiac Surgery Using Cardiopulmonary Bypass Machine: A Preliminary Study [Phase 2, Phase 3]

View source ↗

Summary

A preliminary study evaluating the role of dexmedetomidine for myocardial protection in pediatric patients with cyanotic congenital heart disease undergoing ope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease in Children

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Congenital Heart Disease in Children, Cardiopulmonary Bypass | Phase 2, Phase 3 | Status: COMPLETED